Dedicated To Delivering Accountability, Maximizing Compensation And Facilitating Your Recovery


If you or a loved one has been diagnosed with cancer after using prescription or over-the-counter Zantac (ranitidine), we urge you to contact our pharmaceutical liability attorneys by filling out our form or calling Peter Angelos Law. The FDA has recently withdrawn these medications from the market, and you may be entitled to pursue legal action.

What Is Zanta?

Zantac is an antacid and antihistamine primarily used to treat and prevent heartburn, but it can also be used to treat stomach ulcers, gastroesophageal reflux disease (GERD) and other gastrointestinal disorders. The drug is known as ranitidine in its generic form.

Drug safety officials in the U.S. and Europe have launched an investigation into whether Sanofi heartburn medication, Zantac, and other generic versions made by numerous manufacturers contain levels of the probable carcinogen N-nitrosodimethylamine (NDMA) that could pose a danger to patients.

What Is NDMA?

NDMA is a common industrial byproduct and is a contaminant found in small quantities in meat, vegetables, dairy and water. It is classified as a probable human carcinogen, meaning that it is a substance that could cause cancer when consumed in certain quantities.

Contact The Pharmaceutical Liability Attorneys At Peter Angelos Law Today

The recent discovery of traces of NDMA in the popular drug Zantac and other generic versions of the drug is alarming and demonstrates the necessity of mass manufactured pharmaceutical drug companies to ensure proper steps are being taken to uphold public health. The pharmaceutical liability attorneys at Peter Angelos Law urge you to fill out our form if you or a loved one has taken Zantac or ranitidine that contains NDMAs.

What Companies Are Involved In Litigation?

The discovery of traces of NDMA found in generic Zantac led major drug manufacturers to recall their products. Specific lots of the popular over-the-counter medication have been voluntarily pulled from shelves by numerous manufacturing and distribution companies all over the world, including Sandoz Inc., GlaxoSmithKline – the original manufacturer of branded Zantac – and Dr. Reddy’s. The recent contamination concerns led Sandoz Inc. to halt the distribution of its product indefinitely until further decisions are made regarding the safety of the product. Sandoz Inc. will voluntarily recall all quantities and lots of ranitidine hydrochloride (Zantac) that have expiration dates between April 30, 2020, and March 31, 2021, as those lots have been confirmed to be contaminated with NDMA.